Search for: "Myriad Genetic Laboratories" Results 61 - 80 of 155
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Feb 2013, 12:42 pm by Christopher Holman
Myriad Genetics, history is in a sense repeating itself. [read post]
14 Apr 2013, 5:29 pm by Antoinette Konski
Castanias is representing defendants-respondents Myriad Genetics Inc. [read post]
4 Feb 2013, 6:34 am by Lyle Denniston
Myriad Genetics, Inc., on the Court’s docket as 12-398). [read post]
1 Sep 2015, 9:30 pm by Natalie Punchak
As an example, they emphasize that prior to the Supreme Court’s invalidation of Myriad Genetics’ patents on the BRCA1 and BRCA2 genes in 2013, just one lab could legally sequence those genes. [read post]
1 Aug 2011, 8:13 am by Stefanie Levine
  Some Plaintiffs, such as cancer patients, claimed standing based on the fact that they could not afford the costs of the genetic tests or obtain a second opinion, due to Myriad being the exclusive provider for this test in the United States. [read post]
21 Nov 2011, 11:53 am by Stephen Jenei
Brief for Arup Laboratories, Inc., and Laboratory Conporation of America Holdings  Brief for the of American College of Medical Genetics et al. [read post]
21 Feb 2012, 8:55 pm by Antoinette Konski
Patenting of isolated DNA also is argued to prevent the improvement of genetic tests and unnecessarily impedes innovation and research. [read post]
31 Mar 2014, 12:11 am by Isaac
Prometheus Laboratories from 2012 and Association for Molecular Genetics v. [read post]
5 Apr 2010, 10:12 am by Joe Consumer
"I think Myriad Laboratory is a very reputable company. [read post]
1 Mar 2012, 9:37 am by Suzanne Ito
A 2011 article from the New York Times suggested that withholding this data may provide a competitive benefit to Myriad over other laboratories after their patent expires. [read post]
25 Aug 2011, 1:13 pm by Sandra Park, Women's Rights Project
However, because a company called Myriad Genetics controls the patents on the BRCA1 and BRCA2 genes, there is only one laboratory in the United States that provides BRCA sequencing — Myriad's. [read post]
20 May 2010, 2:27 pm by Gene Quinn
This innovation breathes new importance into the Bilski case and into the Federal Circuit ultimately reversing Judge Sweet’s decision invalidating the Myriad Genetics patents, which we all know they will do. [read post]
17 Apr 2013, 11:50 am
The company provides expensive diagnostic tests based on the patented isolated DNA sequences (denominated BRACAnalysis) and actively tried to stop competing laboratories from performing unlicensed BRAC tests (cease and desist letters were sent, inter alia, to the Genetics and IVF Institute and the University of Pennsylvania's Genetic Diagnostic Laboratory in 1998 (head here for a more detailed account of the facts that gave rise to the case). [read post]
16 Jun 2014, 5:03 am by Dennis Crouch
Myriad Genetics Genetic diagnostic patents Myriad will not “impede non-commercial, academic research that uses patented technology licensed or owned by us… Myriad will continue its practice of not interfering with laboratories conducting genetic testing on patients for the purpose of confirming a test result provided by Myriad.. [read post]
1 Aug 2011, 8:13 am by Stefanie Levine
  Some Plaintiffs, such as cancer patients, claimed standing based on the fact that they could not afford the costs of the genetic tests or obtain a second opinion, due to Myriad being the exclusive provider for this test in the United States. [read post]
5 Apr 2011, 2:43 pm by Rachel Myers, ACLU
Patent and Trademark Office (USPTO), Myriad Genetics and the University of Utah Research Foundation, which hold the patents on the genes, BRCA1 and BRCA2. [read post]